In the multivariate analysis, the effects of age and social determinants on primary care visits remained robust ( p = 0.010 and p = 0.020, respectively), while the effect of social determinants on pharmaceutical costs showed borderline significance ( p = 0.049).
In PXG, the rs12997[G/G] genotype showed a significant trend towards increased risk of the disease (OR = 2.04, 95% CI = 0.99–4.18, p = 0.049) but did not survive the Bonferroni correction.
There was a difference in perception of normal body size of borderline significance for participants with no obese members vs. obese members living outside the home vs. at least one obese member living in the home (ANOVA, p = 0.049, Table 3 ).
4d , red data, median change = −0.207 a.u., p = 0.005, signed-rank and HB tests), and the boundary separation showed a trend towards being smaller (Fig. 4e , red data; median change = −0.025 a.u., p = 0.049, signed-rank and HB tests; Fig. 4e is not significant).
Thus, a similar effect of age at onset was observed for ADL progression ( figure 5B ) as for SARA, although it was less marked, being only detected when comparing patients with onset before age 8 years with those with onset at age 8 years or later, and only marginally significant ( p = 0.049).
We found no significant differences in any of the identified factors between geographical regions, except in dyspnoea, where the P- value was at the threshold of significance ( P = .049) and we found no differences based on sex.
Summer (September 2016), Spring (April 2017), and Fall (September 2017) produced significant clustering within the CCA plot, although the clustering of Spring samples was barely significant (p = 0.049).
The difference between the groups was marginally statistically significant when these three outliers were excluded ( P value=.049), with the intervention group on average reporting lower consumption than the control group.
GCase activity showed a trend to reduction by 33% (p=NS) in wt/ N370S GBA and was 98% decreased (p=0.049) in N370S GBA / N370S GBA when compared to controls, when measured at pH 5.4 in the presence of sodium taurocholate.
Multivariate analysis revealed borderline significance for two age categories (56–65 years, P=0.049; over 65 years, P=0.058) and those who have seen 600–800 patients per year (P=0.056).
While there was no difference between groups at baseline or 6-months follow-up, the intervention arm had a marginally significant (p = 0.049) increase in the median SEAMS score over this period ( Table 4 ).
As previously noted ( 21 ), the only difference in demographics was in body mass index (BMI) across the 4 groups (ANOVA P = 0.038), with a numerically higher BMI in patients with IBS-D with high fecal BA excretion; although this did not reach statistical significance on Dunn multiple comparison test, the difference was significant ( P = 0.049) by the direct Mann-Whitney rank-sum test between the 2 groups.
However, we must underline that the P value corresponding to the comparison of the percentage of patients having required a bladder catheterization is borderline significant ( P = .049).
We observed borderline significant correlations between changes in activated CD4+ T cell and Cesarean section (r = 0.20, p = 0.049, Fig. 5a,b ) and islet autoimmunity (r = 0.24, p = 0.052, Fig. 5c,d ).
After stratifying female patients on the basis of their fasting serum glucose levels with a fasting glucose > 140 mg/dL correlating with suboptimal glycemic control, a fasting glucose > 140 mg/dL was significantly associated with an abnormal CFRAdn Ratio: odds ratio (confidence interval) 3.36 (1.24–9.07) p = 0.017, though was not significantly associated with an abnormal %ΔCBFAch. Amongst males, HbA1c was negatively associated with an abnormal %ΔCBFAch with borderline significance: odds ratio (confidence interval) 0.67 (0.46–1.00) p = 0.049, though was not significantly associated with an abnormal CFRAdn Ratio.